Obesity and diabetes are deeply connected, each one makes the other worse.

And this loop is becoming increasingly common in India as metabolic issues rise.

GLP-1 drugs like Semaglutide and Tirzepatide are helping break this cycle by reducing appetite, improving insulin response and controlling sugar spikes.

For many high-risk patients, they’re proving to be genuine game-changers.

But these are powerful medications effective only under proper medical supervision, not self-medication or social media trends.

Science-based treatment, the right guidance and consistent lifestyle habits together create real, long-term results.

Follow @diabesmartindia for more evidence-backed insights.